Visium Asset Management
View Older Stories View More Recent Stories
-
Veracyte (VCYT) Misses Q1 EPS by 1c
-
Veracyte Announces First Quarter 2016 Financial Results
-
Washington's 'unprecedented overreach' causing losses: asset manager Visium
-
Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners
-
UPDATE: Visium Asset Management Being Investigated by DoJ, SEC
-
SomaLogic Raises Up to $60.5 Million From Visium Healthcare Partners to Support Strategic Growth Initiatives
-
RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Form SC 13G Cynapsus Therapeutics Filed by: Visium Asset Management, LP
-
Top U.S. hedge funds bet on Morgan Stanley and AIG
-
Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: Visium Asset Management, LP
-
Form SC 13G/A NephroGenex, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G/A SPECTRANETICS CORP Filed by: Visium Asset Management, LP
-
Form SC 13G/A Pacira Pharmaceuticals, Filed by: Visium Asset Management, LP
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: Visium Asset Management, LP
-
Form SC 13G/A Wright Medical Group Filed by: Visium Asset Management, LP
-
Form SC 13G/A Quotient Ltd Filed by: Visium Asset Management, LP
-
Form SC 13G/A Syneron Medical Ltd. Filed by: Visium Asset Management, LP
-
Form SC 13G/A Esperion Therapeutics, Filed by: Visium Asset Management, LP
-
Form SC 13G/A MOMENTA PHARMACEUTICALS Filed by: Visium Asset Management, LP
-
Form SC 13G/A CymaBay Therapeutics, Filed by: Visium Asset Management, LP
-
Form SC 13G/A Ascendis Pharma A/S Filed by: Visium Asset Management, LP
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Visium Asset Management, LP
-
Form SC 13G/A Lipocine Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G/A Zeltiq Aesthetics Inc Filed by: Visium Asset Management, LP
-
Form SC 13G/A Enzymotec Ltd. Filed by: Visium Asset Management, LP
-
Form SC 13G/A ALBANY MOLECULAR RESEARC Filed by: Visium Asset Management, LP
-
Form SC 13G/A Vericel Corp Filed by: Visium Asset Management, LP
-
Form SC 13G/A CONMED CORP Filed by: Visium Asset Management, LP
-
Form SC 13G/A BIO BLAST PHARMA LTD. Filed by: Visium Asset Management, LP
-
Form SC 13G/A APPLIED GENETIC TECHNOLO Filed by: Visium Asset Management, LP
-
Form SC 13G/A Sientra, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: Visium Asset Management, LP
-
Form SC 13G/A Axovant Sciences Ltd. Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Dec 31
-
Form SC 13G Sage Therapeutics, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G LA JOLLA PHARMACEUTICAL Filed by: Visium Asset Management, LP
-
U.S. hedge funds boast lower losses as markets tumble further
-
Caution, teamwork trumped bravado for some hedge funds in 2015
-
Ackman's Pershing Square ends 2015 with 20.5 pct drop
-
Visium Asset Management, LP Raises Stake in Zeltiq Aesthetics (ZLTQ) to 5.6%
-
Form SC 13G Zeltiq Aesthetics Inc Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Sep 30
-
RedHill Biopharma Reports Results for the Third Quarter of 2015
-
2nd Annual IP Dealmakers Forum, Dec 7-8 in NYC, to Bridge Investment and Intellectual Property Communities
-
Form SC 13G/A SPECTRANETICS CORP Filed by: Visium Asset Management, LP
-
Form SC 13G AQUINOX PHARMACEUTICALS, Filed by: Visium Asset Management, LP
-
Ackman's Pershing Square hedge fund drops 9.2 percent in August
-
Hedge fund Visium Balanced rose in August, up 11.2 percent YTD
-
Form SC 13G Ascendis Pharma A/S Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Jun 30

